Candesartan Tablets 8 mg (Candesartan Cilexetil)

Adult dose

For essential hypertension, the recommended initial and maintenance dose of candesartan cilexetil is 8 to 16 mg orally once daily. If blood pressure is not sufficiently controlled after 4 weeks of treatment at 16 mg once daily, the dosage may be increased to a maximum of 32 mg once daily. Elderly patients do not require dosage adjustment. Patients with reduced intravascular effective blood volume should start with an initial dose of 4 mg with careful monitoring.

Child dose

Safety and efficacy for adolescents and children under 18 years of age have not been established.

This medication may cause serious harm to the fetus and newborn, especially during pregnancy. Therefore, it should be discontinued immediately if pregnancy is confirmed. It should not be used in patients with an allergy to this medication or who are pregnant, patients with severe liver impairment or cholestasis, a history of angioedema, primary hyperaldosteronism, and certain genetic lactose intolerant patients. Caution should be exercised when administering this medication to elderly patients or those with hyperkalemia, liver dysfunction, heart valve issues, ischemic heart disease, renal artery stenosis, or impaired renal function. Side effects such as dizziness, back pain, and respiratory infections may occur during this medication, and in heart failure patients, hypotension, hyperkalemia, and renal function damage may occur, necessitating regular blood tests. Symptoms such as sudden low blood pressure, shock, fainting, or loss of consciousness may appear, so if these symptoms occur, immediate consultation with a medical professional is necessary. This medication may enhance the effects when used with other antihypertensives, and special caution is warranted when used in combination with certain diuretics or potassium-sparing medications as blood potassium levels may dangerously rise. It is advisable for pregnant or breastfeeding women to avoid using this medication, and, if absolutely necessary, breastfeeding should be discontinued. The safety and efficacy for children and adolescents under 18 years of age have not been established, so use should be avoided. In elderly patients, caution should be taken to avoid excessive blood pressure lowering that may increase the risk of stroke. In the event of overdose, symptoms such as hypotension, dizziness, and rapid heartbeat may occur, and in such cases, the patient should be stabilized and receive prompt medical treatment. This medication should be stored out of reach of children and should not be transferred to other containers.

Serious side effects

Urticaria, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, mucosal pain in the mouth/eyes, difficulty breathing or shortness of breath, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis

Mild side effects

Dizziness, back pain, respiratory infections (upper respiratory tract infections, pharyngitis, rhinitis), fatigue, peripheral edema, chest pain, headache, bronchitis, cough, sinusitis, nausea, abdominal pain, diarrhea, vomiting, joint pain, proteinuria, weakness, fever, paresthesia, dyspepsia, gastroenteritis, tachycardia, palpitations, increased creatine kinase, hyperglycemia, hypertriglyceridemia, hyperuricemia, myalgia, epistaxis, anxiety, depression, drowsiness, dyspnea, rash, sweating

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. Additionally, avoid extremely cold or hot places, and it is recommended to store it at room temperature between 1 to 30 degrees Celsius.

Appearance

A bright pink tablet, round and convex on both sides with a dividing line on one side

Package unit

30 tablets/bottle